Urachal carcinoma: a large retrospective multicentric study from the French Genito-Urinary Tumor Group
Guerin, M, Miran, C, Colomba, E, Cabart, M, Herrmann, T, Pericart, S, Maillet, D, Neuzillet, Y, Deleuze, A, Coquan, E, Laramas, M, Thibault, C, Abbar, B, Mesnard, B, Borchiellini, D, Dumont, C, Boughalem, E, Deville, J L, Cancel, M, Saldana, C, Khalil, A, Baciarello, G, Flechon, A, Walz, J, Gravis, G
Published in Frontiers in oncology (19.01.2023)
Published in Frontiers in oncology (19.01.2023)
Get full text
Journal Article
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high-grade gliomas patients: OLA-TMZ-RTE-01
Stefan, D, Lesueur, P, Lequesne, J, Coquan, E, Brachet, P E, Castera, L, Goardon, N, Lacroix, J, Lange, M, Capel, A, Andre, B, Grellard, J-M, Clarisse, B
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study
Charton, E., Baldini, C., Fayet, Y., Schultz, E., Auroy, L., Vallier, E., Italiano, A., Robert, M., Coquan, E., Isambert, N., Moreau, P., Touzeau, C., Le Tourneau, C., Ghrieb, Z., Kiladjian, J.-J., Delord, J.-P., Gomez Roca, C., Vey, N., Barlesi, F., Lesimple, T., Penel, N., Soria, J.-C., Massard, C., Besle, S.
Published in ESMO open (01.08.2023)
Published in ESMO open (01.08.2023)
Get full text
Journal Article
Patients’ perceived tolerance of side effects in phase I cancer clinical trials: A qualitative study
Brédart, A., Bodson, S., Le Tourneau, C., Flahault, C., Bonnetain, F., Beaudeau, A., Coquan, E., Dolbeault, S., Paoletti, X.
Published in European journal of cancer care (01.11.2017)
Published in European journal of cancer care (01.11.2017)
Get full text
Journal Article
Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study
Baldini, C., Charton, E., Schultz, E., Auroy, L., Italiano, A., Robert, M., Coquan, E., Isambert, N., Moreau, P., Le Gouill, S., Le Tourneau, C., Ghrieb, Z., Kiladjian, J.J., Delord, J.P., Roca, C. Gomez, Vey, N., Barlesi, F., Lesimple, T., Penel, N., Soria, J.C., Massard, C., Besle, S.
Published in ESMO open (01.06.2022)
Published in ESMO open (01.06.2022)
Get full text
Journal Article
478P Metronomic oral vinorelbine (MOV) combined with tremelimumab (T) + durvalumab (D): Results of the tumor mutational burden-high (TMB-h) and/or microsatellite instability-high (MSI-h) cohort of the MOVIE study
Hervieu, A., Guigay, J., Borcoman, E., Lavaud, P., Coquan, E., Frenel, J-S., De La Motte Rouge, T., Augereau, P., Cropet, C., Legrand, F., Goncalves, A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
775P Tremelimumab (T) + durvalumab (D) combined with metronomic oral vinorelbine (MOV): Results of the recurrent cervical cancer (RCC) cohort of the MOVIE study
Frenel, J-S., Hervieu, A., Borcoman, E., Coquan, E., Guigay, J., De La Motte Rouge, T., Lavaud, P., Cropet, C., Legrand, F., Gonçalves, A.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1700P Impact of sarcomatoid (S) and rhabdoid (R) components (comp.) on the efficacy of nivolumab (N) +/- ipilimumab (I) in the first-line (L1) treatment of metastatic clear cell renal cell carcinoma (mRCC) in the randomized phase II BIONIKK trial
Vano, Y-A., Hernandez, I., Bennamoun, M., Verkarre, V., Chevreau, C.M., Gross Goupil, M., Tournigand, C., Borchiellini, D., Laguerre, B., Maillet, D., Barthelemy, P., Gravis, G., Coquan, E., Pannier, D., Houede, N., Kotti, S., Fridman, W-H., Sautes-Fridman, C., Sun, C-M., Oudard, S.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1710P Exposure-response (E/R) relationship of nivolumab (N) and ipilimumab (I) in patients (pts) with metastatic renal cell clear cell carcinoma (mRCC) from the randomised phase II BIONIKK study
Blanchet, B., Puszkiel, A.A., Jouinot, A., Bennamoun, M., Maillet, D., Borchiellini, D., Laguerre, B., Pannier, D., Gross Goupil, M., Chevreau, C.M., Barthelemy, P., Tournigand, C., Coquan, E., Gravis, G., Kotti, S., Fridman, W-H., Sautes-Fridman, C., Oudard, S., Sun, C-M., Vano, Y-A.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1977P Efficacy of talazoparib and avelumab as a maintenance treatment in patients with advanced/metastatic urothelial carcinoma (mUC) whose disease did not progress after a first-line platinum-based chemotherapy (PBCT): The GETUG-TALASUR trial
Coquan, E., Boughalem, E., Pouessel, D., Lequesne, J., Calcagno, F., Grellard, J-M., Christy, F., Mahammedi, H., Ladoire, S., Borchiellini, D., Leman, R., Bazille, C., Fontugne, J., Crouzet, L., Flechon, A., Serrate, C., Gravis, G., Clarisse, B., Thiery Vuillemin, A., Joly Lobbedez, F.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial
Kurtz, Jean-Emmanuel, Pujade-Lauraine, Eric, Oaknin, Ana, Belin, Lisa, Leitner, Katharina, Cibula, David, Denys, Hannelore, Rosengarten, Ora, Rodrigues, Manuel, de Gregorio, Nikolaus, Martinez García, Jeronimo, Petru, Edgar, Kocián, Roman, Vergote, Ignace, Pautier, Patricia, Schmalfeldt, Barbara, Gaba, Lydia, Polterauer, Stephan, Mouret Reynier, Marie-Ange, Sehouli, Jalid, Churruca, Cristina, Selle, Frédéric, Joly, Florence, D'Hondt, Véronique, Bultot-Boissier, Émilie, Lebreton, Coriolan, Lotz, Jean-Pierre, Largillier, Rémy, Heudel, Pierre-Etienne, Heitz, Florian
Published in Journal of clinical oncology (20.10.2023)
Published in Journal of clinical oncology (20.10.2023)
Get full text
Journal Article
752P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell cervix carcinoma: Subgroup analysis of the PEVOsq basket trial
Le Saux, O., Borel, C., Ghiringhelli, F., Bigot, F., Vansteene, D., Chaltiel, R., Cousin, S., Durando, X., Coquan, E., Abdeddaim, C., Jeannot, E., Guerini Rocco, E., Frige, G., Francisco, M., Halladjian, M., Kamal, M., Legrand, F., Jimenez, M., Cabarrou, B., Le Tourneau, C.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2406P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell carcinoma of the penis: Subgroup analysis of the PEVOsq basket trial
Coquan, E., Gomez-Roca, C.A., Lambert, A., You, B., Vansteene, D., Bigot, F., Cousin, S., Ajgal, Z. Castel, Jeannot, E., Guerini Rocco, E., Frige, G., Mazzarella, L., Francisco, M., Servant, N., Halladjian, M., Kamal, M., Legrand, F., Jimenez, M., Cabarrou, B., Le Tourneau, C.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
788P Urachal carcinoma: Large retrospective multicentric GETUG-AFU study
Guerin, M., Colomba-Blameble, E., Miran, C., Herrmann, T., Pericart, S., Maillet, D., Neuzillet, Y., Deleuze, A., Thibault, C., Coquan, E., Dumont, C., Boughalem, E., Borchiellini, D., Mesnard, B., Khalil, A., Baciarello, G., Fléchon, A., Walz, J., Gravis, G.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
715P Nivolumab in pretreated metastatic penile squamous cell carcinoma: Results of the penile cohort from the French AcSé prospective program
Pouessel, D., Beylot-Barry, M., Esma, S.B., De Pontville, M., Coquan, E., Mahammedi, H., Gavoille, C., Ghiringhelli, F., Dereure, O., Spano, J-P., Tosi, D., Fléchon, A., Pannier, D., Augereau, P., Gambotti, L., Legrand, F., Simon, C., Lamrani-Ghaouti, A., Chevret, S., Marabelle, A.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
406TiPPhase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high-grade gliomas patients: OLA-TMZ-RTE-01
Stefan, D, Lesueur, P, Lequesne, J, Coquan, E, Brachet, P E, Castera, L, Goardon, N, Lacroix, J, Lange, M, Capel, A, Andre, B, Grellard, J-M, Clarisse, B
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1619O High clinical benefit rates of single agent pembrolizumab in selected rare sarcoma histotypes: First results of the AcSé Pembrolizumab study
Blay, J-Y., Chevret, S., Penel, N., Bertucci, F., Bompas, E., Saada-Bouzid, E., Eymard, J-C., Lotz, J-P., Coquan, E., Schott, R., Soulié, P., Linassier, C., Le Cesne, A., Brahmi, M., Hoog-Labouret, N., Legrand, F., Simon, C., Lamrani-Ghaouti, A., Ray-Coquard, I.L., Massard, C.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
260 Impact of BRCA & PD-L1 in EOC patients receiving standard 1st line therapy +/- Pembrolizumab: Exploratory analyses from the NeoPembrOV Study (GINECO)
Le Saux, O, Savoye, AM, Mouret-Reynier, MA, Schiffler, C, Derbel, O, Isabelle, T, Kalbacher, E, Gouerant, S, Martinez, A, Cornila, C, Martinez, M, Bengrine Lefevre, L, Priou, F, Cloarec, N, Venat-Bouvet, L, Angelergues, A, Berton, D, Collard, O, Coquan, E, Ray-Coquard, I
Published in International journal of gynecological cancer (12.10.2021)
Published in International journal of gynecological cancer (12.10.2021)
Get full text
Journal Article
High clinical benefit rates of pembrolizumab in very rare sarcoma histotypes: First results of the AcSé pembrolizumab study
Blay, J.-Y., Penel, N., Ray-Coquard, I.L., Schott, R., Saada-Bouzid, E., Bertucci, F., Chevreau, C.M., Bompas, E., Coquan, E., Cousin, S., Soulié, P., Le Cesne, A., Mir, O., Ryckewaert, T., Brahmi, M., Hoog-Labouret, N., Couch, D., Chevret, S., Soria, J.-C., Massard, C.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article